Prognostic Value of GRACE Score and Left Ventricular Ejection Fraction in Non-ST-Segment Elevation Myocardial Infarction

IF 1.7 3区 医学 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Yong Hoon Kim, Ae-Young Her, Seung-Woon Rha, Cheol Ung Choi, Byoung Geol Choi, Soohyung Park, Jung Rae Cho, Min-Woong Kim, Ji Young Park, Myung Ho Jeong
{"title":"Prognostic Value of GRACE Score and Left Ventricular Ejection Fraction in Non-ST-Segment Elevation Myocardial Infarction","authors":"Yong Hoon Kim,&nbsp;Ae-Young Her,&nbsp;Seung-Woon Rha,&nbsp;Cheol Ung Choi,&nbsp;Byoung Geol Choi,&nbsp;Soohyung Park,&nbsp;Jung Rae Cho,&nbsp;Min-Woong Kim,&nbsp;Ji Young Park,&nbsp;Myung Ho Jeong","doi":"10.1155/joic/3838955","DOIUrl":null,"url":null,"abstract":"<p><b>Background:</b> To provide more useful information due to the lack of published results to date, we analyzed the 3-year clinical outcomes of patients with non-ST-segment elevation myocardial infarction (NSTEMI) using the Global Registry of Acute Coronary Events (GRACE) score and the degree of left ventricular ejection fraction (LVEF).</p><p><b>Methods:</b> In total, 4558 patients were stratified into two groups: GRACE score &gt; 140 (group A) and GRACE score ≤ 140 (Group B). Each group was further subdivided into heart failure (HF) with reduced EF (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF). The primary outcome was all-cause mortality, and the secondary outcomes were cardiac death (CD), non-CD, recurrent MI, and hospitalization for HF (HHF).</p><p><b>Results:</b> After adjustment, in Group A, the 3-year rates of all-cause mortality (<i>p</i> &lt; 0.001 for all), CD, and HHF were higher in the HFrEF subgroup than in the HFmrEF and HFpEF subgroups, with similar outcomes between the HFmrEF and HFpEF subgroups. In Group B, the HFrEF subgroup had higher CD (<i>p</i> = 0.019) and HHF rates than did the HFmrEF subgroup and higher all-cause mortality (<i>p</i> = 0.001), CD (<i>p</i> &lt; 0.001), and HHF rates than the HFpEF subgroup. All-cause mortality rate between the HFrEF and HFmrEF subgroups was similar, whereas the HFmrEF subgroup had a higher all-cause mortality rate than did the HFpEF subgroup (<i>p</i> = 0.022). Group A had worse clinical outcomes than Group B across all LVEF subgroups.</p><p><b>Conclusion:</b> Although the HFrEF subgroup had a higher all-cause mortality rate than did the HFpEF subgroup, all-cause mortality patterns between the HFrEF and HFmrEF subgroups and between the HFmrEF and HFpEF subgroups varied according to the GRACE score. However, broader studies with a larger number of patients are needed.</p>","PeriodicalId":16329,"journal":{"name":"Journal of interventional cardiology","volume":"2025 1","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1155/joic/3838955","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of interventional cardiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1155/joic/3838955","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: To provide more useful information due to the lack of published results to date, we analyzed the 3-year clinical outcomes of patients with non-ST-segment elevation myocardial infarction (NSTEMI) using the Global Registry of Acute Coronary Events (GRACE) score and the degree of left ventricular ejection fraction (LVEF).

Methods: In total, 4558 patients were stratified into two groups: GRACE score > 140 (group A) and GRACE score ≤ 140 (Group B). Each group was further subdivided into heart failure (HF) with reduced EF (HFrEF), HF with mildly reduced EF (HFmrEF), and HF with preserved EF (HFpEF). The primary outcome was all-cause mortality, and the secondary outcomes were cardiac death (CD), non-CD, recurrent MI, and hospitalization for HF (HHF).

Results: After adjustment, in Group A, the 3-year rates of all-cause mortality (p < 0.001 for all), CD, and HHF were higher in the HFrEF subgroup than in the HFmrEF and HFpEF subgroups, with similar outcomes between the HFmrEF and HFpEF subgroups. In Group B, the HFrEF subgroup had higher CD (p = 0.019) and HHF rates than did the HFmrEF subgroup and higher all-cause mortality (p = 0.001), CD (p < 0.001), and HHF rates than the HFpEF subgroup. All-cause mortality rate between the HFrEF and HFmrEF subgroups was similar, whereas the HFmrEF subgroup had a higher all-cause mortality rate than did the HFpEF subgroup (p = 0.022). Group A had worse clinical outcomes than Group B across all LVEF subgroups.

Conclusion: Although the HFrEF subgroup had a higher all-cause mortality rate than did the HFpEF subgroup, all-cause mortality patterns between the HFrEF and HFmrEF subgroups and between the HFmrEF and HFpEF subgroups varied according to the GRACE score. However, broader studies with a larger number of patients are needed.

Abstract Image

GRACE评分和左室射血分数对非st段抬高型心肌梗死的预后价值
背景:由于缺乏迄今为止发表的结果,为了提供更多有用的信息,我们使用急性冠状动脉事件全球登记(GRACE)评分和左室射血分数(LVEF)的程度分析了非st段抬高型心肌梗死(NSTEMI)患者的3年临床结果。方法:4558例患者分为GRACE评分≤140组(A组)和GRACE评分≤140组(B组)。每组进一步细分为心力衰竭(HF)伴EF降低(HFrEF)、心力衰竭伴EF轻度降低(HFmrEF)和心力衰竭伴EF保留(HFpEF)。主要结局是全因死亡率,次要结局是心源性死亡(CD)、非CD、复发性心肌梗死和因心衰住院(HHF)。结果:调整后,在A组中,HFrEF亚组的3年全因死亡率(p < 0.001)、CD和HHF高于HFmrEF和HFpEF亚组,HFmrEF和HFpEF亚组之间的结果相似。在B组中,HFrEF亚组的CD (p = 0.019)和HHF发生率高于HFmrEF亚组,全因死亡率(p = 0.001)、CD (p < 0.001)和HHF发生率高于HFpEF亚组。HFrEF和HFmrEF亚组之间的全因死亡率相似,而HFmrEF亚组的全因死亡率高于HFpEF亚组(p = 0.022)。在所有LVEF亚组中,A组的临床结果都比B组差。结论:尽管HFrEF亚组的全因死亡率高于HFpEF亚组,但HFrEF亚组与HFmrEF亚组之间以及HFmrEF与HFpEF亚组之间的全因死亡率模式因GRACE评分而异。然而,需要对更多的患者进行更广泛的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of interventional cardiology
Journal of interventional cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.80
自引率
0.00%
发文量
81
审稿时长
6-12 weeks
期刊介绍: Journal of Interventional Cardiology is a peer-reviewed, Open Access journal that provides a forum for cardiologists determined to stay current in the diagnosis, investigation, and management of patients with cardiovascular disease and its associated complications. The journal publishes original research articles, review articles, and clinical studies focusing on new procedures and techniques in all major subject areas in the field, including: Acute coronary syndrome Coronary disease Congenital heart diseases Myocardial infarction Peripheral arterial disease Valvular heart disease Cardiac hemodynamics and physiology Haemostasis and thrombosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信